A meta-analysis of more than 20 phase 3 trials found no clear survival differences by sex or age in metastatic NSCLC but ...

A systematic review and meta-analysis evaluate treatment-emergent adverse events associated with trastuzumab deruxtecan in ...

Subgroup analysis revealed a pronounced effect among patients receiving MAC. In this cohort, 6-month grade 2-4 GFS was 35.7% with placebo vs 60.7% with ustekinumab (OR 2.78 for failure; 80% CI, 1.19-6 ...

Global phase 3 OCEANIC-STROKE randomized 12,327 patients to asundexian 50 mg daily vs placebo on background antiplatelets, with follow-up to 31 months. Treatment effects were consistent across TOAST ...

In a prospective imaging study of 200 adults with lung cancer, photon-counting CT reduced radiation exposure, had fewer ...

Q4 2025 Management View Christopher Viehbacher, President, CEO & Director, opened by stating, "We finished the year strongly ...

Researchers conducted a cross-sectional analysis to explore the relationship between sleep disorders and rheumatoid arthritis prevalence among US adults.

Pegcetacoplan injections slowed progression of geographic atrophy but had no impact on visual acuity in a real-world setting, ...

Results suggest research is closer to making recombinant factor VIIa work ...

Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced new clinical data presented at the 2026 Tandem ...

Investigators evaluated dual immune checkpoint inhibitors for safety and efficacy in patients with brain metastases from rare cancers.

Fractyl Health offers a buy-the-dip opportunity after an overreaction to underwhelming six-month pilot data for its Revita ...